BIOMERICA INC (BMRA)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$2.31+4.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · BMRA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 4.5 | 4.5 | 5.3 | 5.4 | 5.3 | 18.9 | 7.2 | 6.7 | 5.2 | 5.6 | 5.8 | 5.1 | 5.0 | 5.1 | 6.5 | 6.1 |
| Total Revenues | 4.5 | 4.5 | 5.3 | 5.4 | 5.3 | 18.9 | 7.2 | 6.7 | 5.2 | 5.6 | 5.8 | 5.1 | 5.0 | 5.1 | 6.5 | 6.1 |
| Cost of Revenues | 4.1 | 4.1 | 4.8 | 4.8 | 4.9 | 15.9 | 6.8 | 5.0 | 3.9 | 3.8 | 3.8 | 3.6 | 3.4 | 3.5 | 4.0 | 3.8 |
| Gross Profit | 0.4 | 0.4 | 0.5 | 0.6 | 0.4 | 3.0 | 0.4 | 1.7 | 1.3 | 1.8 | 2.0 | 1.5 | 1.5 | 1.7 | 2.4 | 2.3 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 4.9 | 4.9 | 4.6 | 5.5 | 6.1 | 5.7 | 5.7 | 2.5 | 2.0 | 1.8 | 1.8 | 1.6 | 1.5 | 1.5 | 1.5 | 1.4 |
| R&D Expenses | 0.8 | 0.8 | 1.0 | 1.5 | 1.6 | 1.8 | 2.2 | 1.9 | 1.7 | 1.4 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.3 |
| Operating Income | (5.3) | (5.3) | (5.1) | (6.4) | (7.2) | (4.5) | (7.5) | (2.7) | (2.4) | (1.5) | (1.0) | (0.8) | (0.7) | (0.4) | 0.5 | 0.5 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | 1.6 | 1.6 | 0.2 | 0.4 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Asset Writedown | — | — | — | — | 0.0 | 0.2 | 0.0 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (3.8) | (3.8) | (5.0) | (5.9) | (7.1) | (4.5) | (7.4) | (2.3) | (2.4) | (1.4) | (0.9) | (0.8) | (0.6) | (0.4) | 0.5 | — |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.7 | (0.3) | (0.2) | (0.0) | 0.1 |
| Net Income | ||||||||||||||||
| Net Income | (3.8) | (3.8) | (5.0) | (6.0) | (7.1) | (4.5) | (7.4) | (2.7) | (2.4) | (1.5) | (0.9) | (1.5) | (0.3) | (0.2) | 0.5 | 0.5 |
| Per Share | ||||||||||||||||
| Basic EPS | — | (1.30) | (2.16) | (0.36) | (0.50) | (0.36) | (0.62) | (0.26) | (0.26) | (0.17) | (0.11) | (0.20) | (0.04) | (0.03) | 0.08 | 0.08 |
| Diluted EPS | — | (1.30) | (2.16) | (0.36) | (0.50) | (0.36) | (0.62) | (0.26) | (0.26) | (0.17) | (0.11) | (0.20) | (0.04) | (0.03) | 0.07 | 0.08 |
| Basic Weighted Avg Shares | — | 2.9 | 2.3 | 16.8 | 14.2 | 12.7 | 11.9 | 10.2 | 9.2 | 8.6 | 8.3 | 7.6 | 7.6 | 7.4 | 7.0 | — |
| Diluted Weighted Avg Shares | — | 2.9 | 2.3 | 16.8 | 14.2 | 12.7 | 11.9 | 10.2 | 9.2 | 8.6 | 8.3 | 7.6 | 7.6 | 7.4 | 7.5 | 7.1 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (5.2) | (5.1) | (6.3) | (7.1) | (4.2) | (7.4) | (2.6) | (2.2) | (1.3) | (0.7) | (0.6) | (0.4) | (0.2) | 0.7 | 0.7 |
| EBIT | (5.3) | (5.3) | (5.1) | (6.4) | (7.2) | (4.5) | (7.5) | (2.7) | (2.4) | (1.5) | (1.0) | (0.8) | (0.7) | (0.4) | 0.5 | 0.5 |
| Effective Tax Rate | -0.6% | — | — | — | -0.7% | -0.5% | -0.2% | -0.3% | -1.0% | -2.2% | -77.5% | -88.4% | 48.7% | 49.4% | -2.4% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.